Literature DB >> 17697143

Expression of the human Cathepsin L inhibitor hurpin in mice: skin alterations and increased carcinogenesis.

Markus Walz1, Sabine Kellermann, Matilda Bylaite, Birgit Andrée, Ulrich Rüther, Ralf Paus, Jennifer E Kloepper, Julia Reifenberger, Thomas Ruzicka.   

Abstract

The serine protease inhibitor (serpin) hurpin (serpin B13) is a cross class-specific inhibitor of the cysteine protease Cathepsin (Cat) L. Cat L is involved in lysosomal protein degradation, hair follicle morphogenesis, epidermal differentiation and epitope generation of antigens. Hurpin is a 44 kDa protein which is expressed predominantly in epidermal cells. In psoriatic skin samples, hurpin was strongly overexpressed when compared with normal skin. Keratinocytes overexpressing hurpin showed increased resistance towards UVB-induced apoptosis. To further analyse the functional importance of this inhibitor, we have generated transgenic mice with deregulated Cat L activity by expressing human hurpin in addition to the endogenous mouse inhibitor. The three independent transgenic lines generated were characterized by identical effects excluding insertional phenotypes. Macroscopically, mice expressing human hurpin are characterized by abnormal abdominal fur. The number of apoptotic cells and caspase-3 positive cells was reduced after UV-irradiation in transgenic animals compared with wild-type mice. Interestingly, after chemical carcinogenesis, transgenic mice showed an increased susceptibility to develop skin cancer. Array analysis of gene expression revealed distinct differences between wild-type and hurpin-transgenic mice. Among others, differentially expressed genes are related to antigen presentation and angiogenesis. These results suggest an important role of Cat L regulation by hurpin which might be of clinical relevance in human skin diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697143     DOI: 10.1111/j.1600-0625.2007.00579.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  6 in total

1.  Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis.

Authors:  J Dennemärker; T Lohmüller; J Mayerle; M Tacke; M M Lerch; L M Coussens; C Peters; T Reinheckel
Journal:  Oncogene       Date:  2009-12-21       Impact factor: 9.867

2.  Protective role of cathepsin L in mouse skin carcinogenesis.

Authors:  Fernando Benavides; Carlos Perez; Jorge Blando; Oscar Contreras; Jianjun Shen; Lisa M Coussens; Susan M Fischer; Donna F Kusewitt; John DiGiovanni; Claudio J Conti
Journal:  Mol Carcinog       Date:  2011-05-02       Impact factor: 4.784

3.  Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation.

Authors:  Tommy Weiss-Sadan; Gal Itzhak; Farnusch Kaschani; Zhanru Yu; Mohamed Mahameed; Adi Anaki; Yael Ben-Nun; Emmanuelle Merquiol; Boaz Tirosh; Benedikt Kessler; Markus Kaiser; Galia Blum
Journal:  Mol Cell Proteomics       Date:  2019-04-22       Impact factor: 5.911

4.  Knockdown of cathepsin L sensitizes ovarian cancer cells to chemotherapy.

Authors:  Hongmei Zhang; Luosheng Zhang; Lixia Wei; Xingwang Gao; L I Tang; Wei Gong; N A Min; L I Zhang; Yawei Yuan
Journal:  Oncol Lett       Date:  2016-04-26       Impact factor: 2.967

5.  Ultraviolet A Enhances Cathepsin L Expression and Activity via JNK Pathway in Human Dermal Fibroblasts.

Authors:  Qing-Fang Xu; Yue Zheng; Jian Chen; Xin-Ya Xu; Zi-Jian Gong; Yun-Fen Huang; Chun Lu; Howard I Maibach; Wei Lai
Journal:  Chin Med J (Engl)       Date:  2016-12-05       Impact factor: 2.628

Review 6.  Mechanisms Applied by Protein Inhibitors to Inhibit Cysteine Proteases.

Authors:  Livija Tušar; Aleksandra Usenik; Boris Turk; Dušan Turk
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.